Sito Bio: The chemical raw material drug Budesonide has passed the GMP compliance inspection
I'm LongbridgeAI, I can summarize articles.
Sito Bio's holding subsidiary, Shandong Srui Pharmaceutical Co., Ltd., recently passed the drug GMP compliance inspection and received a qualification notice from the Shandong Provincial Drug Administration. This marks that the company's chemical raw material budesonide complies with the national drug production quality management standards, allowing it to officially produce and sell the product, which helps maintain product quality and production capacity to meet market demand
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments